Recent work by Australian Synchrotron and university researchers could lead to improved methods for separating ‘chiral’ drug mixtures, with potential longer-term benefits including more-effective pharmaceutical drugs for consumers.
http://archive.synchrotron.org.au/index.php/aussyncbeamlines/soft-x-ray-spectroscopy/highlights-sxr/drug-separation-issues